Craneware plc (LON:CRW - Get Free Report)'s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,966.26 ($26.17) and traded as low as GBX 1,920 ($25.55). Craneware shares last traded at GBX 1,940 ($25.82), with a volume of 28,233 shares trading hands.
Wall Street Analyst Weigh In
Several research firms have commented on CRW. Shore Capital reiterated a "buy" rating on shares of Craneware in a research note on Thursday, May 8th. Berenberg Bank reiterated a "buy" rating and issued a GBX 2,800 ($37.26) price objective on shares of Craneware in a research note on Tuesday, March 11th.
View Our Latest Analysis on Craneware
Craneware Trading Down 1.0%
The firm has a fifty day moving average of GBX 1,725.10 and a two-hundred day moving average of GBX 1,966.08. The company has a market cap of £825.30 million, a PE ratio of 70.97 and a beta of 0.28. The company has a current ratio of 0.63, a quick ratio of 1.00 and a debt-to-equity ratio of 12.22.
Craneware Cuts Dividend
The firm also recently announced a dividend, which was paid on Thursday, April 17th. Shareholders of record on Thursday, March 20th were given a dividend of GBX 13.50 ($0.18) per share. The ex-dividend date of this dividend was Thursday, March 20th. This represents a yield of 0.71%. Craneware's dividend payout ratio is presently 107.14%.
Insider Activity
In other Craneware news, insider Will Whitehorn acquired 1,911 shares of Craneware stock in a transaction that occurred on Thursday, April 24th. The stock was acquired at an average cost of GBX 1,584 ($21.08) per share, for a total transaction of £30,270.24 ($40,285.12). Insiders own 19.28% of the company's stock.
Craneware Company Profile
(
Get Free Report)
The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Craneware, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.
While Craneware currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
